Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH antagonist vs MPA to prevent premature LH surge in poor ovarian responders
ChiCTR-IPR-17010906Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of ganirelix and medroxyprogesterone acetate in infertility (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Incidence of premature LH surge. Started Mar 2017; status: recruiting.
02
Drugs
ganirelixmedroxyprogesterone acetate
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR-IPR-17010906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010906.